Literature DB >> 17360608

Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases.

Erica A Moehle1, E A Moehle, Jeremy M Rock, J M Rock, Ya-Li Lee, Y L Lee, Yann Jouvenot, Y Jouvenot, Russell C DeKelver, R C Dekelver, Philip D Gregory, P D Gregory, Fyodor D Urnov, F D Urnov, Michael C Holmes, M C Holmes.   

Abstract

Efficient incorporation of novel DNA sequences into a specific site in the genome of living human cells remains a challenge despite its potential utility to genetic medicine, biotechnology, and basic research. We find that a precisely placed double-strand break induced by engineered zinc finger nucleases (ZFNs) can stimulate integration of long DNA stretches into a predetermined genomic location, resulting in high-efficiency site-specific gene addition. Using an extrachromosomal DNA donor carrying a 12-bp tag, a 900-bp ORF, or a 1.5-kb promoter-transcription unit flanked by locus-specific homology arms, we find targeted integration frequencies of 15%, 6%, and 5%, respectively, within 72 h of treatment, and with no selection for the desired event. Importantly, we find that the integration event occurs in a homology-directed manner and leads to the accurate reconstruction of the donor-specified genotype at the endogenous chromosomal locus, and hence presumably results from synthesis-dependent strand annealing repair of the break using the donor DNA as a template. This site-specific gene addition occurs with no measurable increase in the rate of random integration. Remarkably, we also find that ZFNs can drive the addition of an 8-kb sequence carrying three distinct promoter-transcription units into an endogenous locus at a frequency of 6%, also in the absence of any selection. These data reveal the surprising versatility of the specialized polymerase machinery involved in double-strand break repair, illuminate a powerful approach to mammalian cell engineering, and open the possibility of ZFN-driven gene addition therapy for human genetic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360608      PMCID: PMC1802009          DOI: 10.1073/pnas.0611478104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells.

Authors:  Ted H J Kwaks; Arie P Otte
Journal:  Trends Biotechnol       Date:  2006-02-07       Impact factor: 19.536

Review 2.  Therapeutic gene targeting.

Authors:  R J Yáñez; A C Porter
Journal:  Gene Ther       Date:  1998-02       Impact factor: 5.250

Review 3.  Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae.

Authors:  F Pâques; J E Haber
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Gene regulatory proteins and their interaction with DNA.

Authors:  A Klug
Journal:  Ann N Y Acad Sci       Date:  1995-06-30       Impact factor: 5.691

5.  In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence.

Authors:  Y Choo; I Sánchez-García; A Klug
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

6.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

7.  Conservative inheritance of newly synthesized DNA in double-strand break-induced gene conversion.

Authors:  Grzegorz Ira; Dominik Satory; James E Haber
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

8.  Gene conversion tracts from double-strand break repair in mammalian cells.

Authors:  B Elliott; C Richardson; J Winderbaum; J A Nickoloff; M Jasin
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 9.  Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair.

Authors:  Lorraine S Symington
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

Review 10.  Sensing and repairing DNA double-strand breaks.

Authors:  Stephen P Jackson
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

View more
  155 in total

1.  Genome editing in human stem cells.

Authors:  Susan M Byrne; Prashant Mali; George M Church
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Zinc-finger nucleases: how to play two good hands.

Authors:  Mark Isalan
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

3.  Genome editing with CompoZr custom zinc finger nucleases (ZFNs).

Authors:  Keith Hansen; Matthew J Coussens; Jack Sago; Shilpi Subramanian; Monika Gjoka; Dave Briner
Journal:  J Vis Exp       Date:  2012-06-14       Impact factor: 1.355

Review 4.  Genome editing with engineered zinc finger nucleases.

Authors:  Fyodor D Urnov; Edward J Rebar; Michael C Holmes; H Steve Zhang; Philip D Gregory
Journal:  Nat Rev Genet       Date:  2010-09       Impact factor: 53.242

5.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

Authors:  Russell C DeKelver; Vivian M Choi; Erica A Moehle; David E Paschon; Dirk Hockemeyer; Sebastiaan H Meijsing; Yasemin Sancak; Xiaoxia Cui; Eveline J Steine; Jeffrey C Miller; Phillip Tam; Victor V Bartsevich; Xiangdong Meng; Igor Rupniewski; Sunita M Gopalan; Helena C Sun; Kathleen J Pitz; Jeremy M Rock; Lei Zhang; Gregory D Davis; Edward J Rebar; Iain M Cheeseman; Keith R Yamamoto; David M Sabatini; Rudolf Jaenisch; Philip D Gregory; Fyodor D Urnov
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

Review 6.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

Review 7.  Genetic therapies for cystic fibrosis lung disease.

Authors:  Patrick L Sinn; Reshma M Anthony; Paul B McCray
Journal:  Hum Mol Genet       Date:  2011-03-21       Impact factor: 6.150

Review 8.  Custom-designed zinc finger nucleases: what is next?

Authors:  J Wu; K Kandavelou; S Chandrasegaran
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

Review 9.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

10.  Targeted mutagenesis in zebrafish using customized zinc-finger nucleases.

Authors:  Jonathan E Foley; Morgan L Maeder; Joseph Pearlberg; J Keith Joung; Randall T Peterson; Jing-Ruey J Yeh
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.